Navigation Links
Positive Results Using Affitech-Identified Human Antibody That,Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model,Reported by Peregrine

OSLO, Norway--(BUSINESS WIRE)--Apr 23, 2007 - Affitech AS, the human antibody therapeutics company announced today that Peregrine Pharmaceuticals, Inc. reported positive in vivo test results of R3, a fully human monoclonal antibody developed by Affitech, in a pancreatic cancer model at the recently concluded Centennial Annual Meeting of the American Association for Cancer Research (AACR). R3 has been designed by the two companies for selective blocking of VEGF (vascular endothelial growth factor) binding to VEGF receptor 2, as opposed to other anti-angiogenic agents which block activity of both VEGF receptors.

The R3 antibody, which was generated by Affitech's phagemid antibody library screening method, when tested by Peregrine on a pancreatic cancer model, showed significant reduction of the growth, vascularization and macrophage infiltration of pancreatic tumors in mice. This is the first antibody from Affitech's library that has been tested in a preclinical development model. Peregrine announced that the positive results of R3 antibody support the Company's intent to progress its anti-VEGF program towards clinical trials.

"We are delighted with this in vivo result, " commented Martin Welschof, Ph.D., Chief Executive Officer of Affitech. "Affitech and Peregrine have several collaborative antibody projects. The quality of the antibody and excellent collaborative research by the scientists of our two organizations are contributing to advancing Peregrine's anti-VEGF portfolio. This success also has important implications for accelerating our own human therapeutic antibody program "

Editors notes

Affitech AS is a privately held human therapeutic antibody discovery and development company with headquarters and R&D facilities in Oslo, Norway and its US subsidiary in the San Francisco Bay Area. The Company's current disease focus is oncology and it utilizes two discrete but unique approaches
'"/>




Page: 1 2

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:12/19/2013)... , Dec. 19, 2013 Generic ... overall savings during the last decade, according to ... Association (GPhA). Through innovative utilization management tools, pharmacy ... use of generic drugs, the Pharmaceutical Care Management ... confirms that lower cost generics continue to save ...
(Date:12/19/2013)... 19, 2013  According to Millennium Research Group ... intelligence, the Chinese heart valve device market will ... more mature United States ... by an aging population as well as the ... market will be further bolstered by strong economic ...
(Date:12/19/2013)... STATION, Texas , Dec. 19, 2013 /PRNewswire/ ... chosen to provide Equipment Planning services to the ... in support of the U.S. Army Medical ... awarded by the U.S. Army Corps of Engineers, ... Inc., MEMdata will assist with the Initial Outfitting ...
Breaking Medicine Technology:PCMA: New Study Confirms $217 Billion in Savings from Generic Medications in 2012 2As in the US and Europe, the Entrance of Transcatheter Heart Valve Technologies Will Significantly Bolster the Chinese Heart Valve Device Market 2As in the US and Europe, the Entrance of Transcatheter Heart Valve Technologies Will Significantly Bolster the Chinese Heart Valve Device Market 3MEMdata Announces U.S. Army Project in South Korea 2
... FORT MYERS, Fla., May 11, 2011 Radiation ... radiation therapy centers, today announced financial results for the first ... the first quarter of 2011 were $156.5 million, an increase ... same quarter of 2010. The increase in revenue was principally ...
... 2011 Doctors in Germany are among the first ... with the REVIVE™ SE, a new self-expanding blood clot ... and restore blood flow to the brain in patients ... Inc., a global neuroscience and neurovascular company, received Conformite ...
Cached Medicine Technology:Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 2Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 3Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 4Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 5Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 6Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 7Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 8Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 9Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 10Radiation Therapy Services Holdings, Inc. Reports First Quarter 2011 Financial Results 11Doctors in Germany Among First to Use New Self-Expanding Clot Removal Device for Ischemic Stroke 2Doctors in Germany Among First to Use New Self-Expanding Clot Removal Device for Ischemic Stroke 3
(Date:12/19/2013)... (PRWEB) December 19, 2013 ... Complete EHR, 2014 Edition (Meaningful Use Stage 2) ... The announcement comes less than a month after ... specifically for health and human services provider organizations ... “This certification of our myEvolv™ CareRecord reinforces Netsmart’s ...
(Date:12/19/2013)... of the keys to reducing or preventing health problems ... best integrate physical activity into their daily lives ... significant hurdle to clear on the path to a ... the Rutgers School of NursingCamden, is taking a closer ... in urban areas perceive physical activity. Thompson recently ...
(Date:12/19/2013)... According to a Harris Interactive study, ... Year’s fitness resolution will abandon it by February. ... called “The RISE Experience” is aiming to change all ... computer technology, combined with advanced entertainment systems and an ... kind of fitness philosophy: “immersive entertainment.” , RISE is ...
(Date:12/19/2013)... (PRWEB) December 19, 2013 The US ... revenue over the five years to 2013. Global weather ... production, which directly influence revenue. Sugar prices skyrocketed during ... rainfall that harmed crops in Brazil, the world's leading ... of sugar boosted demand for US downstream sugar products. ...
(Date:12/19/2013)... Boca Raton, FL (PRWEB) December 19, 2013 ... on Anti-Aging, Regenerative and Aesthetic Medicine wrapped up on ... and exhibitors present. Over 3,500 attendees, over 300 exhibiting ... Resort in Las Vegas, NV December 13th - 15th ... and integrative medicine. , Among the over 50 ...
Breaking Medicine News(10 mins):Health News:Netsmart Continues Commitment to Health and Humans Services with Meaningful Use Stage 2 Certification of myEvolv™ CareRecord™ 2Health News:Netsmart Continues Commitment to Health and Humans Services with Meaningful Use Stage 2 Certification of myEvolv™ CareRecord™ 3Health News:Netsmart Continues Commitment to Health and Humans Services with Meaningful Use Stage 2 Certification of myEvolv™ CareRecord™ 4Health News:New ways to promote fitness for urban girls proposed by Rutgers-Camden nursing professor 2Health News:New ways to promote fitness for urban girls proposed by Rutgers-Camden nursing professor 3Health News:Entrepreneur Seeks to Change Face of Fitness by Combining Concert-Style “Immersive Entertainment” with Intense Workout Experience 2Health News:Entrepreneur Seeks to Change Face of Fitness by Combining Concert-Style “Immersive Entertainment” with Intense Workout Experience 3Health News:Sugarcane Harvesting in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Sugarcane Harvesting in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:The American Academy of Anti-Aging Medicine (A4M) Concludes Largest Event in Anti-Aging, Regenerative and Aesthetic Medicine on Sunday, December 15, 2013 2Health News:The American Academy of Anti-Aging Medicine (A4M) Concludes Largest Event in Anti-Aging, Regenerative and Aesthetic Medicine on Sunday, December 15, 2013 3Health News:The American Academy of Anti-Aging Medicine (A4M) Concludes Largest Event in Anti-Aging, Regenerative and Aesthetic Medicine on Sunday, December 15, 2013 4
... hour limits from Rhode Island Hospital has been selected as ... of the American College of Radiology ( JACR ). ... history behind the current resident duty hour requirements, the proposed ... proposed changes. Mainiero, the director of the residency program ...
... of America (GSA) the nation,s largest interdisciplinary ... the federal government,s recent release of the " 2010 ... inclusion of specific advice for older adults. Because ... of adults in the U.S. are overweight or obese, ...
... 3, 2011) For blood cancer patients at high ... transplantation of blood-forming stem cells, is one of best ... most common complication of HSCT is graft-versus-host disease (GVHD), ... when the newly transplanted donor cells recognize the recipient,s ...
... Studies show drinking V8 100% vegetable juice may be a ... may help them manage their weight two areas of ... for Americans. 1 A study conducted by researchers ... one, 8-ounce glass of vegetable juice each day, as part ...
... , WEDNESDAY, Feb. 2 (HealthDay News) -- Close to 100 ... 2009-2010 in China, with no pattern of serious side effects ... evidence surfaced that the swine flu vaccine, as it was ... report published in the Feb. 2 online edition of the ...
... migraine headaches produces lasting good results, with nearly 90 ... five years, follow-up, reports a study in the February ... journal of the American Society of Plastic Surgeons (ASPS). ... were completely eliminated after surgery, according to the new ...
Cached Medicine News:Health News:Paper by Rhode Island Hospital physician selected among best of 2010 by JACR 2Health News:GSA supports new US call for improved nutrition and physical activity 2Health News:Early infusion of donor T cells prevents graft versus host disease in blood cancer patients 2Health News:Early infusion of donor T cells prevents graft versus host disease in blood cancer patients 3Health News:Research suggests V8 100% vegetable juice can help people meet key dietary guidelines 2Health News:Last Year's H1N1 Flu Vaccine Was Safe, Study Finds 2Health News:Last Year's H1N1 Flu Vaccine Was Safe, Study Finds 3Health News:Migraine surgery offers good long-term outcomes 2
... floor model centrifuge. High throughput, refrigeration ... speed with all windshield rotors, lifetime ... at a remote personal computer or ... automatic imbalance detection and shut down, ...
... centrifuge. Mobile space saver, very powerful, ... accessories, analog controls, large bright digital ... patented pendulum system), guard barrier, dual ... rugged motor, tough steel casing with ...
... Powerful programmable refrigerated ... high capacity rotors, large ... labile sample protection, true ... control, lifetime reproducibility, true ...
Powerful refrigerated bench-top centrifuge. Very powerful, high capacity rotors, large choice of accessories, heat labile sample protection, guard barrier, dual lid interlock, easy to use, variable c...
Medicine Products: